NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis
Top Cited Papers
Open Access
- 1 September 2006
- journal article
- review article
- Published by Elsevier BV in Osteoarthritis and Cartilage
- Vol. 14 (9), 839-848
- https://doi.org/10.1016/j.joca.2006.04.008
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Defining and Assaying RNAi in Mammalian CellsMolecular Cell, 2005
- Effects of vitamin E on the NF-κB pathway in rats treated with the peroxisome proliferator, ciprofibrateToxicology and Applied Pharmacology, 2004
- Molecular imaging of the transcription factor NF-κB, a primary regulator of stress responseMutation Research, 2004
- Evolving concepts of rheumatoid arthritisNature, 2003
- Gene deletion of NF-κB p50 does not alter the hepatic inflammatory response to ischemia/reperfusionJournal of Hepatology, 2002
- TNF-α-mediated apoptosis in chondrocytes sensitized by MG132 or actinomycin DBiochemical and Biophysical Research Communications, 2002
- Nuclear transcription factor-κB as a target for cancer drug developmentLeukemia, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammationBritish Journal of Pharmacology, 2002
- The Effect of Dexamethasone on the Expression of Activated NF-κB in Adjuvant ArthritisClinical Immunology and Immunopathology, 1997